Liver diseases, especially fatty liver, are rising fast, even among non-drinkers. Liver specialist Dr Saurabh Sethi shares 9 ...

Introduction Liver cirrhosis and other chronic liver diseases is a serious public health problem, and its incidence, morbidity, and mortality have increased in recent years (1). In 2019, 1691.0 ...

Traditional cardiovascular risk assessment tools underperform among individuals with metabolic dysfunction-associated steatotic liver disease.

Adding bile acids as farnesoid X receptor agonists to the culture medium supported the growth and development of unique stem ...

Liver cirrhosis is a serious condition. It damages the liver over time. Common causes include alcohol, hepatitis, and fatty ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects nearly one in three adults around the globe. It ...

We wanted to find out if rifaximin could be used to prevent and treat hepatic encephalopathy in people with cirrhosis; whether it does this better than no drug treatment, a dummy pill (placebo), or ...

Kennedy Jr. and the members of his newly appointed vaccine panel are casting doubt on the hepatitis B vaccine and the ...

It's well-documented that Americans began drinking more during the pandemic. In Wisconsin, alcohol-related deaths increased ...

Vaccinations are another tool to slow disease. People with cirrhosis should be vaccinated against hepatitis A and B, as these ...

Use of Sodium-Glucose Cotransporter 2 (SGLT-2) inhibitors among adults with cirrhosis receiving diuretic therapy was ...